Bayer Launches New Healthy-Aging Ecosystem for Consumers

BayerCombining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging space by offering consumers new tools to help them support their healthy-aging journey with its new Age Factor™ ecosystem.

The ecosystem approach is designed to go "beyond the pill" by addressing key consumer needs at multiple steps in their health journey from awareness, education, and engagement to assessment and action. Powered by digital tools, the goal is to help consumers make smarter, more informed decisions about their own health.

"Precision health is making self-care even more consumer-centric," said Julio Triana, president of the Consumer Health division of Bayer. "Our aging journeys are unique to us all and new digital tools are enabling offerings to be more tailor made. With this multi-facedted approach, we are educating and enabling consumers to to make informed decisions about their self-care in new and exciting ways."

One A Day® Age Factor™ Cell Defense

As people age, their cells naturally become less effective at managing everyday stressors. Cellular or biological age - how a person's cells are aging - may not always match one’s chronological age. Research suggests that genetics contributes only about 20% to the cellular aging process, with lifestyle (diet, exercise, stress) playing a large role. One A Day® Age Factor™ Cell Defense has key ingredients to help support consumers' cellular health and resilience as part of their healthy aging journey.

"The healthy aging space can be a confusing one for consumers with countless products making big promises," said Abbie Lennox, Head of Regulatory, Medical, Safety, Quality and Compliance for Consumer Health at Bayer. "That's why we took a science-led approach that focuses on the holistic factors that impact cellular age by equipping consumers with a product containing a key ingredient that helps defend against oxidative stress along with personalized recommendations and insights to best chart their own course."

Designed to provide holistic support along their healthy aging journey, the Age Factor™ ecosystem includes a dietary supplement, a wellness companion app, and a Chronomics biological age test to measure and track personal progress over time.

  • The Age Factor™ wellness companion app provides valuable insights and lifestyle recommendations based on a person’s current habits while tracking progress over time.
  • The Chronomics biological age test is a simple and convenient way to measure biological age through a non-invasive saliva test. Once sent to the lab, the sample will be analyzed and results received within weeks.

Benefit claims for Age Factor Cell Defense supplement have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Precision Health

Technology advancements have enabled a wave of new digital products such as diagnostics, apps, and therapeutics to help consumers better manage their health. An analysis conducted for Bayer found over 80 percent of consumers globally already demand greater healthcare personalization and precision consumer health products will make up 10-20 percent of the total consumer health market in 2030 worth an estimated value of $20-40 billion.

Last year Bayer launched a new business unit focused on developing new precision consumer health products.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros.

Most Popular Now

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...